Article
Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study.
Cancer immunology, immunotherapy : CII - 1 Mar 2021
Wang Qinchuan, Ye Yuanqing, Yu Hao, Lin Shu-Hong, Tu Huakang, Liang Dong, Chang David W, Huang Maosheng, Wu Xifeng
Abstract excerpt
BACKGROUND: The clinical predictors and biological mechanisms for localized prostate cancer (PCa) outcomes remain mostly unknown. We aim to evaluate the role of serum immune-checkpoint-related (ICK) proteins and genetic variations in predicting outcomes of localized PCa. METHODS: We profiled the serum levels of 14 ICK-related proteins (BTLA, GITR, HVEM, IDO, LAG-3, PD-1, PD-L1, PD-L2, Tim-3, CD28, CD80, 4-1BB,...
Topics
- Aged
- Biomarkers
- Cohort Studies
- Disease Progression
- Disease Susceptibility
- Genetic Variation
- Genotype
- Humans
- Immune Checkpoint Proteins
- Immunophenotyping
